Sign in →

Test Code HEPATITIS B CORE ANTIBODY IgM HEPATITIS B CORE ANTIBODY IgM

Department

Immunology

Specimen Type

Serum

Method

Chemiluminescent Microparticle Assay

Container

No additive with gel (gold top)

Special Requirements

Centrifuge sample within 24 hours post draw.

Standard Volume

4.5ml

Minimum Volume

3ml

Pediatric Volume

1.6ml

Ship Temperature

Refrigerated

Stability Refrigerated

7 days

Stability Room Temp

72 hours

Stability Frozen

>7 days

CPT Code

86705

Days Test Set Up

Monday through Friday

Group Components

HEPATITIS B CORE ANTIBODY, IGM

Clinical Information

Hepatitis B virus (HBV) is endenic throughout the world and is the major cause of liver disease. HBV is transmitted through the direct contact with blood and body fluids. Common modes of transmission include blood transfusion, needle puncture, direct contact with open wounds, sexual contact, and mother-neonate contact during birth. The average incubation for HBV infections is 6 to 8 weeks. Infections is usually asymptomatic. Common clincal symptoms include malaise, fever, gastroenteritis, and icterus. HBV infection can result in typical icteric hepatitis, subclinical anti-icteric hepatitis, fulminant hepatitis, or chronic hepatitis. Anti-HB core IgM titers increase rapidly, peak during the acute infection state of HBV infection, and then fall to a relatively low level as the patient recovers or becomes a chronic carrier. Anti-HBc IgM may be the only specific marker for the diagnosis of acute HBV infection.

Test Use

For the qualitative determination of IgM response to hepatitis B virus core antigen. This assay may be used in combination with other hepatitis B virus marker assays to define the clinical status of known HBV infected patients or cam be combined with other HBV, HAV, and HCV assays for the diagnosis of patients presenting symptoms of acute viral hepatitis.

Cautions

The performance of the assay has not be established for populations of immunocompromised or immunosupressed patients, cord blood, neonatal specimens, cadaver specimens, or body bluids.
A reactive anti-HB core IgM result does not exclude co-infection by another hepatitis virus.

Interpretation

Negative are considered nonreactive for IgM antibodies to hepatitis B core antigen.
Positive are considerede reactive for IgM antibodies to hepatitis B core antigen.